Order Article Reprints

Gwark S, Ahn H-S, Yeom J, Yu J, Oh Y, Jeong JH, Ahn J-H, Jung KH, Kim S-B, Lee HJ, et al. Plasma Proteome Signature to Predict the Outcome of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Cancers. 2021; 13(24):6267. https://doi.org/10.3390/cancers13246267

Gwark, Sungchan, Hee-Sung Ahn, Jeonghun Yeom, Jiyoung Yu, Yumi Oh, Jae Ho Jeong, Jin-Hee Ahn, Kyung Hae Jung, Sung-Bae Kim, Hee Jin Lee, and et al. 2021. "Plasma Proteome Signature to Predict the Outcome of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy" Cancers 13, no. 24: 6267. https://doi.org/10.3390/cancers13246267

Gwark, S., Ahn, H. -S., Yeom, J., Yu, J., Oh, Y., Jeong, J. H., Ahn, J. -H., Jung, K. H., Kim, S. -B., Lee, H. J., Gong, G., Lee, S. B., Chung, I. Y., Kim, H. J., Ko, B. S., Lee, J. W., Son, B. H., Ahn, S. H., Kim, K., & Kim, J. (2021). Plasma Proteome Signature to Predict the Outcome of Breast Cancer Patients Receiving Neoadjuvant Chemotherapy. Cancers, 13(24), 6267. https://doi.org/10.3390/cancers13246267